BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 32472950)

  • 1. The Clinical Significance of Neuroendocrine Features in Invasive Breast Carcinomas.
    Lai BS; Tsang JY; Poon IK; Shao Y; Chan SK; Tam FK; Cheung SY; Shea KH; Tse GM
    Oncologist; 2020 Sep; 25(9):e1318-e1329. PubMed ID: 32472950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. INSM1 is a novel prognostic neuroendocrine marker for luminal B breast cancer.
    Razvi H; Tsang JY; Poon IK; Chan SK; Cheung SY; Shea KH; Tse GM
    Pathology; 2021 Feb; 53(2):170-178. PubMed ID: 32951906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive analysis of clinicopathologic features and p53 mutation in neuroendocrine neoplasms of the breast: experience from a large academic center.
    Shafi S; Hu Y; Parwani AV; Ding Q; Li Z
    Breast Cancer Res Treat; 2022 Dec; 196(3):463-469. PubMed ID: 36260193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of neuroendocrine markers in non-neuroendocrine endometrial carcinomas.
    Moritz AW; Schlumbrecht MP; Nadji M; Pinto A
    Pathology; 2019 Jun; 51(4):369-374. PubMed ID: 31040050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SOX11 is a sensitive and specific marker for pulmonary high-grade neuroendocrine tumors.
    Yu L; Dong Y; Xue J; Xu S; Wang G; Kuang D; Duan Y
    Diagn Pathol; 2022 Jan; 17(1):2. PubMed ID: 34996493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroendocrine differentiation correlates with hormone receptor expression and decreased survival in patients with invasive breast carcinoma.
    Kwon SY; Bae YK; Gu MJ; Choi JE; Kang SH; Lee SJ; Kim A; Jung HR; Kang SH; Oh HK; Park JY
    Histopathology; 2014 Apr; 64(5):647-59. PubMed ID: 24117859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast cancer with neuroendocrine differentiation: an update based on the latest WHO classification.
    Tsang JY; Tse GM
    Mod Pathol; 2021 Jun; 34(6):1062-1073. PubMed ID: 33531618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroendocrine carcinomas of the breast.
    Rovera F; Masciocchi P; Coglitore A; La Rosa S; Dionigi G; Marelli M; Boni L; Dionigi R
    Int J Surg; 2008; 6 Suppl 1():S113-5. PubMed ID: 19167937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. INSM1 Expression in Breast Neoplasms with Neuroedocrine Features.
    Metovic J; Castellano I; Marinelli E; Osella-Abate S; Sapino A; Cassoni P; Papotti M
    Endocr Pathol; 2021 Dec; 32(4):452-460. PubMed ID: 34008122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Synaptophysin, Chromogranin and CD56 in adenocarcinoma and squamous cell carcinoma of the lung lacking morphological features of neuroendocrine differentiation: a retrospective large-scale study on 1170 tissue samples.
    Kriegsmann K; Zgorzelski C; Muley T; Christopoulos P; Thomas M; Winter H; Eichhorn M; Eichhorn F; von Winterfeld M; Herpel E; Goeppert B; Stenzinger A; Herth FJF; Warth A; Kriegsmann M
    BMC Cancer; 2021 May; 21(1):486. PubMed ID: 33933015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue microarray analysis of neuroendocrine differentiation and its prognostic significance in breast cancer.
    Makretsov N; Gilks CB; Coldman AJ; Hayes M; Huntsman D
    Hum Pathol; 2003 Oct; 34(10):1001-8. PubMed ID: 14608533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinicopathologic features of primary renal neuroendocrine carcinoma].
    Wang XH; Lu X; He B; Jiang YX; Yu WJ; Wang H; Zhang W; Li YJ
    Zhonghua Bing Li Xue Za Zhi; 2018 Nov; 47(11):851-856. PubMed ID: 30423609
    [No Abstract]   [Full Text] [Related]  

  • 13. Prognostic implications of neuroendocrine differentiation and hormone production in patients with Stage I nonsmall cell lung carcinoma.
    Pelosi G; Pasini F; Sonzogni A; Maffini F; Maisonneuve P; Iannucci A; Terzi A; De Manzoni G; Bresaola E; Viale G
    Cancer; 2003 May; 97(10):2487-97. PubMed ID: 12733148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of novel neuroendocrine marker insulinoma-associated protein 1 (INSM1) in genitourinary high-grade neuroendocrine carcinomas: An immunohistochemical study with specificity analysis and comparison to chromogranin, synaptophysin, and CD56.
    Chen JF; Yang C; Sun Y; Cao D
    Pathol Res Pract; 2020 Jun; 216(6):152993. PubMed ID: 32381384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroendocrine Neoplasms of the Breast: The Latest WHO Classification and Review of the Literature.
    Ozaki Y; Miura S; Oki R; Morikawa T; Uchino K
    Cancers (Basel); 2021 Dec; 14(1):. PubMed ID: 35008357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of apocrine differentiation markers in neuroendocrine breast carcinomas of aged women.
    Sapino A; Righi L; Cassoni P; Papotti M; Gugliotta P; Bussolati G
    Mod Pathol; 2001 Aug; 14(8):768-76. PubMed ID: 11504836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulinoma-associated Protein 1 (INSM1) Is a Better Marker for the Diagnosis and Prognosis Estimation of Small Cell Lung Carcinoma Than Neuroendocrine Phenotype Markers Such as Chromogranin A, Synaptophysin, and CD56.
    Sakakibara R; Kobayashi M; Takahashi N; Inamura K; Ninomiya H; Wakejima R; Kitazono S; Yanagitani N; Horiike A; Ichinose J; Matsuura Y; Nakao M; Mun M; Nishio M; Okumura S; Motoi N; Ito T; Miyazaki Y; Inase N; Ishikawa Y
    Am J Surg Pathol; 2020 Jun; 44(6):757-764. PubMed ID: 32118626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of calretinin in high-grade hormone receptor-negative invasive breast carcinomas: correlation with histological and molecular subtypes.
    Micello D; Bossi A; Marando A; Dainese E; Sessa F; Capella C
    Virchows Arch; 2017 Jul; 471(1):13-21. PubMed ID: 28550498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroendocrine Marker Expression in Primary Non-neuroendocrine Epithelial Tumors of the Ovary: A Study of 551 Cases.
    Kendall Bártů M; Němejcová K; Michálková R; Bui QH; Drozenová J; Fabian P; Fadare O; Hausnerová J; Laco J; Matěj R; Méhes G; Šafanda A; Singh N; Škapa P; Špůrková Z; Stolnicu S; Švajdler M; Lax SF; McCluggage WG; Dundr P
    Int J Gynecol Pathol; 2024 Mar; 43(2):123-133. PubMed ID: 37406366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of neuroendocrine markers in different molecular subtypes of breast carcinoma.
    Wachter DL; Hartmann A; Beckmann MW; Fasching PA; Hein A; Bayer CM; Agaimy A
    Biomed Res Int; 2014; 2014():408459. PubMed ID: 24701575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.